alexa Melanoma Patient Derived Tumorgrafts [PDX] Bridge The Gap Between Genomics And Molecularly Informed Medicine
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Translational & Personalized Medicine
August 05-07, 2013 Holiday Inn Chicago-North Shore, IL, USA

B.J. Nickoloff
ScientificTracks Abstracts: Transl Med
DOI: 10.4172/2161-1025.S1.008
Abstract
Malignant melanoma (MM) contains thousands of somatic DNA alterations. As affordability and faster turn-around times for identification of druggable targets specific for each patient improves, together with limited number of therapeutic agents available, a growing gap is emerging as to identification of the right drug(s) for the patient at the right time. To further complicate personalized medicine, frequent acquired drug resistance arises, and failure to kill all tumor cells using single agents. Indeed, MM is notorious for resistance to killing. Thus, rational therapeutic combinations promoting rapid onset of apoptosis and preventing drug resistance is highly desirable. Using patient-derived tumorgrafts it is possible to study responses of MM within in vivo three-dimensional context. Using a collection of such tumorgrafts spanning the genomic landscape, together with agents such as BRAF inhibitors and MEK inhibitors, clinically relevant tumor responses, including acquired drug resistance can be modeled. These models are now being used for identification of drug resistance switches, and ideal combination therapy regimens that prevent drug resistance. As dozens of ?avatar? mice can be created from a single patient sample, various drug combinations, scheduling, etc. can be more rapidly tested than would be achievable in a clinical trial setting. We envision results from tumorgraft models actually serving as informative tools for clinical trial design. Ideally, a sufficient number of tumorgraft models genomically characterized, and biologically tested with rationally designed and optimized therapeutic cocktails could be used to ?best-fit? models from previous patients aligned with newly diagnosed MM patients approach to guide molecularly informed treatment protocols.
Biography
B.J. Nickoloff, M.D., Ph.D. is currently Professor and Director of the Nicholas V. Perricone M.D. Division of Dermatology at Michigan State University College of Human Medicine, and Director (acting) of the Center for Translational Medicine at the Van Andel Institute. He is also the Medical Director of Dermatopathology at the Lack Cancer Center, St. Mary?s Hospital, and Trinity Health System in Grand Rapids, MI. He has published over 365 articles and numerous book chapters and is the editor of three books, and presented lectures worldwide.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

biochemjourn[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version